| Check the appropriate box: | |||||
| o | Preliminary Proxy Statement | ||||
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||||
| o | Definitive Proxy Statement | ||||
| x | Definitive Additional Materials | ||||
| o | Soliciting Material Pursuant to §240.14a-12 | ||||
| GLOBUS MEDICAL, INC. | ||
(Name of Registrant as Specified in Its Charter) | ||
| x | No fee required. | ||||
| o | Fee paid previously with preliminary materials. | ||||
| o | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | ||||


D!
M\@'Z @,"# (4 AT")@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+!
M LL"U0+@ NL"]0, PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#
MQP/3 ^ #[ /Y! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P
M!/X%#044%]@8&!A8&)P8W!D@&
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M',P<]1T>'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@
M;""8(,0@\"$<(4@A=2&A( &YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"
M](-7@[J$'82 A..%1X6KA@Z& OHD#SK3WK)U&ZH=3.C-TS!FRXXQ@J-YM%QN&/W.Q6YV[,?!B8S<.X*6RIV=(6RVTZM3:5(*?#4X3Q.T
M=P-Z!YN74W(+;C5\O[UBM2%XJ[*9N[+MQ6@+6TVVZ@,*#1"O%;=04\N)"E!.
MCYU\6CI)<8>/R;1G[,\WZ7_ ))B/^/W1H)2E*^U'YP%;@?4
MYOX4YM^;X7]JY6G];@?4YOX4YM^;X7]JY7 ]*/RFMU?Y(]5Z%?GM#I?^+-[J
M4I7QD_1*%*4H!2E* 4I2@%*4H!7"E)0"I1 \R:YKSU^J4W+TQ^I,H=$N@/2
MW+5X:8R5WZ\VYL(-V<6-^JH7R"@PA)'/6N:B4GV4^T!(?I ?53/1MZ*3I..V
M"=*Z@7^,HMNQK"M!B,N#>TN3%'P][&B&PX0>Q J'.DGU0?TMO2?NUU
B/4F6?8ZM2-#R49:;"4Z6X5A3JN
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M$F3,EVZV65M:4IXN(<,D>(22-ICO*9=5[D*
QR=*:7!MCP"@VI)2V'G0T%D-)=<6&QK0V$D9EU0P''.IN"W/#
MX\P*YLMBLN-VMBR8]:8=LMT5)0Q$AL)
M99:2220E"0$CN2>P\R:KJ5-W:VPC15]*V9QH>X4T/=7-*@D4I2@%*4H!2E*
M4I2@%*4H!2L-ZB=8.G/2I,$9SDCL07XCK;R0DJ0II]"%I.E)/=/?8U5W2F
MHZ;3MOV&-5:;GQ:DM+=?/L,DI5%=KU:+# =NM\N<6WPF2D.2)3J6FT%2@E(*
ME$ ;4I('O) \S7-WND:RVF9>I@>5'@1W)+H994ZX4(25*"4)!4I6@=) ))[#
MO5;,NY)%92K?8+W#R2QV_(;>B0F+ .-7:/;KK'M;]OG06I =D.^%X)0VO:
M5)4'T$*]P5]R:^+,]TDB8TWCT:!BMIM<^&9B[0D0T,JCJ^V6IILEM2#KNH;2
M=>9U71CB()*4H7>2[%K6W5WYG+GAY2O&,[)W?:]3V:^[(U=ZH8I=5^CSGJLC
MS1N39K%D%JDVF+;,VE74VQAR1$$B/+DJ2VIU""I3S:7N9;"TD$<4FMI+D(-C
MZ170XQ?Y